Categories: News

Virbac : Declaration of the number of shares and voting rights October 2021

 

 

 

 

 

 

 

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS

 

 

 

Information on the total number of voting rights and of shares representing the share capital

(Article 223-16 of the General regulations of the French Financial Market Authority – Autorité

des Marchés Financiers)

 

 

 

 

Quotation place: Euronext Paris

Compartiment A

ISIN code: FR0000031577

 

Date Total number of shares representing the share capital Total number of voting rights
October, 31 2021 8 458 000 Gross total of voting rights : 12 763 910
Net total* of voting rights : 12 757 191

 

Net total* = total number of voting rights attached to the total number of shares net of shares with no voting rights.

 

 

 

 

 

 

 

VIRBAC: Shaping the future of animal health

NYSE Euronext – Compartiment A / Code ISIN: FR0000031577 / MNEMO: VIRP

Corporate Finance: tel. 33 4 92 08 71 32 / Email: finances@virbac.com

Website: www.virbac.com

Attachment

Staff

Recent Posts

Humana Redefines the Member Experience with Agent Assist Built with Google Cloud

Humana introduces Agent Assist to help member advocates deliver faster, more personalized support, enabled by…

2 hours ago

AssureCare Announces Parth Shah’s Promotion to Senior Vice President of Customer Success and Enterprise AI Delivery

CINCINNATI, Feb. 3, 2026 /PRNewswire/ -- AssureCare® LLC, a leading healthcare technology company delivering an…

2 hours ago

Doxim Scales Utility Payments Team to Support Rapid Market Growth

Doxim's Utility Payments Team will drive seamless, omnichannel billing-to-payments solutions for utilities to bridge the…

2 hours ago

Amplifire Recognized by Brandon Hall Group for Breakthrough AI Authoring Technology

BOULDER, Colo., Feb. 3, 2026 /PRNewswire/ -- Amplifire, the leading adaptive learning platform built on patented…

2 hours ago

Cognision Launches Cognision360™: A Unified Platform Transforming Neurobiomarker Acquisition, Processing, and Analysis in CNS Clinical Trials

LOUISVILLE, Ky., Feb. 3, 2026 /PRNewswire/ -- Cognision today unveiled Cognision360™, a groundbreaking web-based platform that consolidates…

2 hours ago